When the transition to menopause starts, women can be plagued by uncomfortable symptoms such as hot flashes, night sweats, sleep problems, mood swings, weight gain, and vaginal dryness. The pharmacolo
Pornography Habit Is Linked to Erectile Dysfunction, Research Suggests
Watching sex films can sometimes be helpful: “It can help people who are anxious about their sexuality get past their apprehensions. Also, if watched together under mutually agreeable conditions, it c
Newly Approved Antipsychotic for Schizophrenia and Bipolar I Disorder Lessens Weight Gain, Studies Show
The U.S. Food and Drug Administration (FDA) announced the approval of a once-daily atypical antipsychotic drug, Lybalvi (olanzapine and samidorphan), to treat adults with schizophrenia and adults with
Can a Rice Krispies Treat Boost Your Workout?
For a preworkout energy boost, some TikTokers are turning to the classic Rice Krispies Treat, claiming the sweet snack helps their workouts.One user, @Ko0maaa, shared about the trend on July 25 in a v
Exercise May Improve Anxiety Symptoms, According to New Research
Most of us know that exercise is good for our heart, our waistline, and for reducing stress. Now a new Swedish study published in the January edition of the Journal of Affective Disorders shows that rAD
More Evidence That Strength Training Boosts Long-Term Health
Does strength training deserve a bit more credit for its role in long-term health? Evidence continues to point to the benefits of muscle-building exercise, and a new meta-analysis has concluded that p
ACR Updates Guidelines for Treatment of Juvenile Idiopathic Arthritis
The American College of Rheumatology (ACR) has issued two updated treatment guidelines for juvenile idiopathic arthritis (JIA). The recommendations reflect more effective medications, the importance o
FDA Names Dupixent as the First and Only Approved Drug to Treat Eosinophilic Esophagitis (EoE)
The U.S. Food and Drug Administration (FDA) announced the approval of Dupixent (dupilumab) to treat eosinophilic esophagitis (EoE) in adults and children ages 12 and older on May 21, 2022. The drug is
FDA Approves New Vitiligo Treatment, Ruxolitinib (Opzelura)
On July 18, the U.S. Food and Drug Administration (FDA) approved ruxolitinib (Opzelura) cream 1.5 percent as a treatment for the most common form of vitiligo, according to a statement by Incyte, the mAD
FDA Approves New Treatment for People With Plaque Psoriasis
The U.S. Food and Drug Administration (FDA) approved Zoryve (roflumilast) cream 0.3 percent for the treatment of plaque psoriasis, including intertriginous areas (where skin rubs against other skin) iAD
AD